Incretin analogs and uses thereof
ZA202003080BActive Publication Date: 2026-10-28ELI LILLY & CO
0 Cites 0 Cited by
Patent Information
- Application Number
- ZA202003080
- Authority / Receiving Office
- ZA · ZA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-12-21
- Filing Date
- 2020-05-25
- Publication Date
- 2026-10-28
- Estimated Expiration
- 2038-12-14
Abstract
Incretin analogs are provided that have activity at each of the GIP, GLP-1 and glucagon receptors. The incretin analogs have structural features resulting in balanced activity and extended duration of action at each of these receptors. Methods also are provided for treating diseases such as diabetes mellitus, dyslipidemia, fatty liver disease, metabolic syndrome, non-alcoholic steatohepatitis and obesity.
Need to check novelty before this filing date? Find Prior Art